These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 16718469)

  • 21. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinational antitumor effect of siRNA against midkine and paclitaxel on growth of human prostate cancer xenografts.
    Takei Y; Kadomatsu K; Goto T; Muramatsu T
    Cancer; 2006 Aug; 107(4):864-73. PubMed ID: 16832814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
    Tong L; Chen W; Wu J; Li H
    Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
    Liao Y; Zou YY; Xia WY; Hung MC
    Cancer Gene Ther; 2004 Sep; 11(9):594-602. PubMed ID: 15272313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retention of paclitaxel in cancer cells for 1 week in vivo and in vitro.
    Mori T; Kinoshita Y; Watanabe A; Yamaguchi T; Hosokawa K; Honjo H
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):665-72. PubMed ID: 16534615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model.
    Devalapally H; Shenoy D; Little S; Langer R; Amiji M
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):477-84. PubMed ID: 16862429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
    Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M
    Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
    Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraperitoneal paclitaxel in the management of ovarian cancer.
    Markman M
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):86-7. PubMed ID: 7481868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
    Zhang J; Wang B
    Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of amifostine and paclitaxel on growth of human ovarian carcinoma xenografts in the severe combined immune-deficient mouse: preliminary results.
    Paine GD; Taylor CW; Lopez MH; Johnson CS; Capizzi RL
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):35-9. PubMed ID: 8783664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma.
    Matsuura M; Suzuki T; Suzuki M; Tanaka R; Ito E; Saito T
    Oncol Rep; 2011 Jan; 25(1):41-7. PubMed ID: 21109955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice.
    Cirstoiu-Hapca A; Buchegger F; Lange N; Bossy L; Gurny R; Delie F
    J Control Release; 2010 Jun; 144(3):324-31. PubMed ID: 20219607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y; Shen K; He CX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts.
    De Stefano I; Battaglia A; Zannoni GF; Prisco MG; Fattorossi A; Travaglia D; Baroni S; Renier D; Scambia G; Ferlini C; Gallo D
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):107-16. PubMed ID: 20848284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The experimental investigation of the invasion and growth of laryngeal cancer by matrix metalloproteinase-2 and matrix metalloproteinase-9 gene silence together].
    Sun YN; Yang BF; Liu M; Guo YL; Tian LL; Jiao H
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):36-9. PubMed ID: 18346378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
    Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Technetium-99m labeled synaptotagmin I C2A detection of paclitaxel-induced apoptosis in non-small cell lung cancer].
    Wang F; Fang W; Ji SD; Meng QL; Li Y; Fan KW; Wang ZZ
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):351-4. PubMed ID: 17892130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different effect of paclitaxel on primary tumor mass, tumor cell contents, and metastases for four experimental human prostate tumors expressing luciferase.
    El Hilali N; Rubio N; Blanco J
    Clin Cancer Res; 2005 Feb; 11(3):1253-8. PubMed ID: 15709196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.